P-198 Multiple neoplasms consist of gastric cancer and hematological malignancy

Multidrug resistance in hematological malignancy.

The recent treatment of hematological malignancies appears to be unsatisfactory in child and adult patients with acute myeloid leukemia and adult patients with acute lymphocytic leukemia. A major problem in the treatment of leukemia is caused by the development of drug resistance to chemotherapeutic agents, which is already present at diagnosis or after chemotherapy as a minimal residual diseas...

Redox Modifications and Hematological Neoplasms-an Overview

Article history Received: 05-02-2014 Revised: 06-08-2014 Accepted: 05-01-2015 Abstract: Due to our current interest in the study of the relationship between hematological malignancies and oxidative stress, in this review we addressed the recent finding regarding this issue, focusing on the clinical findings concerning the oxidative status of patients diagnosed with hematological cancers. This s...

The role of BCL11B in hematological malignancy

The B-cell leukemia/lymphoma 11B (BCL11B) gene is a member of the BCL family which plays a crucial role in the development, proliferation, differentiation and subsequent survival of T cells. BCL11B gene alterations are related to malignant T cell transformation that occurs in hematological malignancies. Remarkably, the BCL11B gene is responsible for the regulation of the apoptotic process and c...

DNA Repair Deficiency Associated with Hematological Neoplasms

Coagulase-negative Staphylococci in Hematological Malignancy

Erik Ahlstrand (2013): Coagulase-negative Staphylococci in Hematological Malignancy. Örebro Studies in Medicine 95. Bacterial infections are common in hematological malignancy. Coagulasenegative staphylococci (CoNS) are among the most prevalent causes of bacteremia in patients with hematological malignancies. In this thesis, different aspects of CoNS in hematological malignancy have been studie...